secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASTROTECH Corp (ASTC)
CIK:        0001001907
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001437749-23-003085
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrotech Q2 FY2023: $46.8M cash, YTD rev $301K, gross margin 38%, new products, $1M buyback
--------------------------------------------------------------------------------

- YTD revenue $301K (6mo ended Dec 31, 2022); gross margin improved to 38% from 18% YoY.
- Cash and liquid investments $46.8M; board authorized $1M share repurchase program on Nov 17, 2022.
- Launched AgLAB 1000-D2 and D2-MVP control system; claims up to 45% improvement in yields and revenues.
- BreathTest-1000 can distinguish infected vs healthy breath samples; collecting data for FDA approval.
- Appointed Bob McFarland to board Jan 27, 2023; completed reverse stock split to regain Nasdaq compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001907/000143774923003085/0001437749-23-003085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001907/000143774923003085/astc20230210_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-003085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer